TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

CUSIP: 89455T109

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common stock, $0.001 par value
Shares outstanding
64,609,137
Total 13F shares
38,823,239
Share change
+327,524
Total reported value
$260,292,697
Price per share
$6.71
Number of holders
117
Value change
+$3,224,800
Number of buys
55
Number of sells
56

Security key

89455T109

Report period

Q3 2025

Institutions

117

Top holders

10

Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
9.9%
from 13D/G
9,411,354
mixed-class rows
$38,428,281 30 Jun 2025
MORGAN STANLEY
13D/G 13F
Company
3.4%
2,091,809
$13,931,448 $0 31 Dec 2024
Aaron Berutti
3/4/5
SVP, Sales
0.32%
205,092
$1,230,552 09 Aug 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
4.8%
3,099,895
$18,227,383 30 Jun 2025
13F
GAGNON SECURITIES LLC
13F
Company
3.5%
2,250,148
$13,230,870 30 Jun 2025
13F
CIBC Private Wealth Group LLC
13F
Company
2.6%
1,687,521
$9,922,623 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.3%
1,517,211
$8,921,201 30 Jun 2025
13F
DEUTSCHE BANK AG\
13F
Company
1.4%
925,545
$5,442,205 30 Jun 2025
13F
First Eagle Investment Management, LLC
13F
Company
1.4%
908,029
$5,339,211 30 Jun 2025
13F
Parkman Healthcare Partners LLC
13F
Company
1.3%
843,998
$4,962,708 30 Jun 2025
13F
Gagnon Advisors, LLC
13F
Company
1.3%
830,270
$4,881,988 30 Jun 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.3%
823,356
$4,841,333 30 Jun 2025
13F
CenterBook Partners LP
13F
Company
0.87%
562,710
$3,308,735 30 Jun 2025
13F
KORNITZER CAPITAL MANAGEMENT INC /KS
13F
Company
0.57%
365,393
$2,148,511 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.55%
354,439
$2,084,101 30 Jun 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.53%
339,334
$1,995,284 30 Jun 2025
13F
Nan Fung Group Holdings Ltd
13F
Company
0.5%
493,584
$253,653 30 Jun 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.47%
302,203
$1,776,951 30 Jun 2025
13F
PARADIGM CAPITAL MANAGEMENT INC/NY
13F
Company
0.42%
268,161
$1,576,787 30 Jun 2025
13F
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
13F
Company
0.39%
249,169
$1,539,864 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.36%
235,155
$1,382,712 30 Jun 2025
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.36%
232,413
$1,366,588 30 Jun 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.34%
221,597
$1,302,319 30 Jun 2025
13F
Arcadia Wealth Management, Inc.
13F
Company
0.32%
209,972
$1,234,635 30 Jun 2025
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.31%
302,743
$155,580 30 Jun 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.29%
188,915
$1,110,820 30 Jun 2025
13F
STIFEL FINANCIAL CORP
13F
Company
0.29%
185,121
$1,088,512 30 Jun 2025
13F
Birchview Capital, LP
13F
Company
0.27%
176,947
$1,040,448 30 Jun 2025
13F
Trexquant Investment LP
13F
Company
0.26%
171,035
$1,005,686 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.25%
163,862
$963,509 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.25%
162,976
$958,299 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.22%
141,725
$832,000 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
0.21%
135,877
$798,956 30 Jun 2025
13F
TAKEDA PHARMACEUTICAL CO LTD
13F
Company
0.21%
203,190
$104,419 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.19%
121,413
$713,908 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.16%
103,205
$606,845 30 Jun 2025
13F
KESTRA PRIVATE WEALTH SERVICES, LLC
13F
Company
0.16%
156,140
$80,240 30 Jun 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.16%
100,317
$589,864 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.16%
100,291
$589,711 30 Jun 2025
13F
Accredited Investors Inc.
13F
Company
0.15%
100,000
$588,000 30 Jun 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.15%
99,215
$583,384 30 Jun 2025
13F
GABELLI FUNDS LLC
13F
Company
0.14%
90,688
$533,245 30 Jun 2025
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.13%
83,272
$489,639 30 Jun 2025
13F
FMR LLC
13F
Company
0.11%
71,927
$422,932 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.11%
70,638
$415,341 30 Jun 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
0.11%
68,900
$405,132 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.1%
64,550
$379,554 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
58,246
$342,486 30 Jun 2025
13F
COMERICA BANK
13F
Company
0.09%
55,000
$323,400 30 Jun 2025
13F
CWA Asset Management Group, LLC
13F
Company
0.08%
83,333
$42,825 30 Jun 2025
13F

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2025

As of 30 Sep 2025, TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,823,239 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GAGNON SECURITIES LLC, MILLENNIUM MANAGEMENT LLC, CIBC Private Wealth Group LLC, JPMORGAN CHASE & CO, First Eagle Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 118 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
122
Q3 2025 holders
117
Holder diff
-5
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .